Latest Taysha Gene Therapies News & Updates

See the latest news and media coverage for Taysha. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Taysha Gene Therapies (Taysha)

Gene therapy company for CNS monogenic diseases

tayshagtx.com
Headquarters
Dallas, United States
Founded year
2020
Company type
Public company
Number of employees
140–200
Industry
Pharmaceuticals

Last updated

Latest news about Taysha Gene Therapies (Taysha)

In short: Taysha completed pivotal REVEAL dosing, reported TSHA-102 gains and expected data and FDA feedback in 1H 2027.

Company announcements

Taysha

Taysha announces proposed $200M public offering of common stock

The offering includes common stock and pre-funded warrants, with underwriters' option for additional 15%.

Unlock all announcements with a

Media coverage

Investing.com

Taysha Gene Therapies prices $200M stock offering at $6 per share By Investing.com

The trial data showed that all 12 patients in the study experienced a gain or regain of developmental milestones by Month 12. This article was...

Unlock all articles with a

Never miss news about Taysha

Track Taysha and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.